🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to evaluate safety and effectiveness of Ilaris in adult and...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-03-29
Trial ID
NCT06838143
Treatments Being Tested
Main Study (CACZ885M2301): The purpose of the pivotal phase of this trial w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04-11
Trial ID
NCT01327846
Treatments Being Tested
This study was designed to assess the safety, tolerability and efficacy of ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-12
Trial ID
NCT02007252
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested
This study is a multi-institution, open-label, Phase 1b/2 clinical trial ev...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2021-03-30
Trial ID
NCT04798339
Treatments Being Tested
This study is a prospective open label evaluation of Canakinumab (Ilaris) f...
Status
Completed
Location
Department of Dermatology, University Hospital Zurich
Start Date
2011-02
Trial ID
NCT01302795
Treatments Being Tested
This was an 18-month, multi-center, open-label, clinical extension study. P...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-11
Trial ID
NCT01470989
Treatments Being Tested
This trial will provide long-term safety, efficacy and tolerability of ACZ8...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01-16
Trial ID
NCT01576367
Treatments Being Tested
The study investigators are interested in learning more about how drugs, th...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2020-03-05
Trial ID
NCT04278404
The purpose of this study is to evaluate whether Canakinumab has beneficial...
Status
Completed
Location
University Medical Clinic Aarau
Start Date
2020-10-23
Trial ID
NCT04510493
Treatments Being Tested